VBI VACCINES (DELAWARE) INC.

VBI Vaccines (Delaware) Inc. specializes in the manufacturing of biological therapeutics and pharmaceutical preparations, with a focused expertise in vaccine development and production for adult immunization programs. The company leverages advanced biomanufacturing processes to produce non-diagnostic biological products, including viral vector-based and recombinant protein vaccines, adhering to cGMP standards. Their technical capabilities encompass upstream and downstream processing, lyophilization, fill-finish operations, and quality control systems tailored to meet stringent FDA and CDC requirements for vaccine safety, potency, and consistency. A key differentiator is their ability to scale complex biological formulations for rapid deployment in public health initiatives, demonstrating proficiency in end-to-end vaccine lifecycle management from process development to commercial-scale production. The contractor has established a consistent track record working with the Department of Health and Human Services, delivering critical vaccine supply solutions aligned with national immunization priorities, and has also supported the Department of Veterans Affairs with specialized pharmaceutical manufacturing for veteran healthcare needs. These engagements reflect a pattern of collaboration on mission-critical, time-sensitive public health programs requiring high regulatory compliance and supply chain reliability. Primary industry focus lies in Biological Product (Except Diagnostic) Manufacturing and Pharmaceutical Preparation Manufacturing, positioning the company at the intersection of biologics innovation and regulated pharmaceutical production. Their vertical specialization centers on adult vaccines, including next-generation platforms designed for enhanced immunogenicity and thermal stability, serving the growing demand for non-influenza, non-pediatric immunization products. VBI Vaccines (Delaware) Inc. is structured as a domestic small business headquartered in Cambridge, Massachusetts, with no federal certifications on record. The company operates as a specialized biopharmaceutical manufacturer with a focused government market presence, serving federal health agencies through direct production and supply of mission-critical biological products.